Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 26 Apr 2023
According to a recent study led by UT Southwestern Medical, patients hospitalized with COVID-19 between March 2020 and December 2021 experienced an increase in the rate of heart attacks, strokes, and other cardiovascular complications.
Read Full NewsA new phase 2 study presented at AES 2025 showed that stiripentol may reduce seizure burden in patients with Lennox-Gastaut syndrome.
Sharon Hesterlee, PhD, President and CEO of the Muscular Dystrophy Association, discussed the 2026 MDA Conference, the significance of its keynote speaker, and the evolving therapeutic landscape in neuromuscular medicine.
A new study presented at AES 2025 examined factors linked to declining surgery for pediatric drug-resistant epilepsy and highlighted variability in candidate selection across centers.
The positive interim findings research represents the first clinical data for ETX101, an investigational cell-type-selective gene therapy, and the first potential one-time disease-modifying treatment for Dravet syndrome.
Lingdolinurad Demonstrates Dose-Dependent Serum Uric Acid Reductions
House Dust Mite SLIT Tablet Well Tolerated in Children With Allergic Asthma
AI in Dermatology: Discussing Downsides to the Adoption of Artificial Intelligence
1.
Five-year survival in patients with unresectable hepatocellular carcinoma sets milestone
2.
Chemo-Free Quadruplet Shows Promise as DLBCL's First Therapy.
3.
New tumor therapy approach reduces costs and side effects while increasing accessibility
4.
Mezigdomide Combinations Show Promise in Multiple Myeloma
5.
We Can Advance Our Patients' Healing by One Step With 1,000 Paper Cranes.
1.
A Comprehensive Guide to Using an ABG Calculator for Accurate Diagnosis
2.
Cancer-Keeper Genes: Novel Therapeutic Targets for Disrupting Tumor Maintenance
3.
Unlocking the Mystery of Methaemoglobinaemia: A New Hope for Treatment
4.
The Revolutionary Treatment of Hodgkin's Lymphoma: A New Hope for the Future
5.
Exploring the Hope of New Treatments for Rhabdomyosarcoma
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part I
2.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
3.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge